The incidence of ABO, Kell and Rh system blood groups in general population of Qazvin, Iran
Archives of Advances in Biosciences,
Vol. 9 No. 4 (2018),
23 December 2018
,
Page 42-46
https://doi.org/10.22037/jps.v9i4.23294
Abstract
Introduction:ABO antigens and the glycoproteins constituting the blood groups such as Kell and Rh systems are the mostly focused blood groups in transfusion medicine. Their importance is tightly associated with the presence of natural isoantibodies, their protein structure, and immunogenicity. The aim of our study was to assess the distribution of major Rh and Kell antigens and the most probable genotype in a normal population of Qazvin city, Iran.Materials and methods:This study was done on 1000 healthy people who were candidates for getting driver’s license. The blood samples were tested for Kell, ABO and major Rh antigens by standard tube agglutination method.Results:Out of 1000 samples studied, the prevalence of RhD was 86.6%. The incidence of other Rh antigens i.e. C, E, c and e was 73%, 29.8%, 72.1%, and 95.9% respectively. The most common phenotype in the samples was DCce and the least one was shown to be CcEe. Kell antigen frequency was 8.2%. On the other hand, 91.8% of people were indicated to be negative for the Kell antigen.Conclusion:Taken together, the amount of the individuals negative for the Kell and Rh system are adequate to provide new policies for identification of these antigens for both blood donors and recipients.
- ABO
- Rh
- Kell
- Blood group
How to Cite
References
McCullough J. Chapter 57: Transfusion Medicine. Blood: Principles and Practice of Hematology first edition Lippincott Williams & Wilkins. 2003;2021.
Sharma DC, Singhal S, Rai S, Iyenger S, Sao S, Jain B. Incidence of Rh antigens, phenotype & probable genotype in the population of Gwalior and Chambal region, Central India. Methodology. 2010.
Barclay S. Red blood cell antigens and human blood groups. Handbook of transfusion medicine: Elsevier; 2001. p. 91-106.
Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;95(2):375-87.
Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Rhesus haemolytic disease: Springer; 1940. p. 41-2.
Daniels G, Reid ME. Blood groups: the past 50 years. Transfusion. 2010;50(2):281-9.
Schonewille H, Van De Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46(2):250-6.
Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox sanguinis. 1990;58(1):50-5.
Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012:blood-2011-11-327361.
Amin-ud-Din M, Fazeli N, Rafiq MA, Malik S. Serological study among the municipal employees of Tehran, Iran. Distribution of ABO and Rh blood groups. The Journal of the Hellenic Society of HAEMATOLOGY. 2004;7(4):502-4.
Keramati MR, Shakibaei H, Kheiyyami MI, Ayatollahi H, Badiei Z, Samavati M, et al. Blood group antigens frequencies in the northeast of Iran. Transfusion and apheresis science. 2011;45(2):133-6.
Khattak ID, Khan TM, Khan P, Shah SMA, Khattak ST, Ali A. Frequency of ABO and Rhesus blood groups in District Swat, Pakistan. Journal of Ayub Medical College Abbottabad. 2008;20(4):127-9.
Sarhan MA, Saleh KA, Bin-Dajem SM. Distribution of ABO blood groups and rhesus factor in Southwest Saudi Arabia. Saudi medical journal. 2009;30(1):116-9.
Daniels G. Human blood groups: John Wiley & Sons; 2008.
Azarkeivan A, Ansari S, Ahmadi MH, Hajibeigy B, Maghsudlu M, Nasizadeh S, et al. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatric hematology and oncology. 2011;28(6):479-85.
Azarkeivan A, Ahmadi MH, Zolfaghari S, Shaiegan M, Ferdowsi S, Rezaei N, et al. RBC alloimmunization and double alloantibodies in thalassemic patients. Hematology. 2015;20(4):223-7.
Shahverdi E, Salehabadi G. Maternal RBC alloantibodies in pregnancy. Hematology and Blood Disorders. 2017;1(1).
Shahverdi E, Moghaddam M, Gorzin F. Maternal red blood cell alloantibodies identified in blood samples obtained from Iranian pregnant women: the first population study in Iran. Transfusion. 2017;57(1):97-101.
Obeidi N, Mankhian AR, Hatami G, Emami H. Antibody screening in patients with thalassemia major. Laboratory Medicine. 2011;42(10):618-21.
Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh Z. RBC alloimmunization in blood transfusion‐dependent β‐thalassemia patients in southern Iran. International journal of laboratory hematology. 2007;29(5):321-6.
- Abstract Viewed: 471 times
- PDF Downloaded: 367 times